Pacific Biosciences of California PACB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's total current liabilities?
- Pacific Biosciences of California (PACB) reported total current liabilities of $65.36M in Q1 2026.
- How has Pacific Biosciences of California's total current liabilities changed year-over-year?
- Pacific Biosciences of California's total current liabilities decreased by 1.9% year-over-year, from $66.6M to $65.36M.
- What is the long-term trend for Pacific Biosciences of California's total current liabilities?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's total current liabilities has grown at a 13.6% compound annual growth rate (CAGR), from $38.5M to $72.83M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.